Brief: Lineage Cell Receives U.S. Patent For Stem-Cell Based Method Of Treating Spinal Cord Injury
04/09/2019 13:09
Sept 4 (Reuters) - Lineage Cell Therapeutics Inc LCTX.A :
* LINEAGE CELL THERAPEUTICS ANNOUNCES ISSUANCE OF U.S.
PATENT FOR
METHOD OF TREATING SPINAL CORD INJURY WITH STEM CELL-DERIVED
OLIGODENDROCYTE PROGENITOR CELLS
Source text for Eikon: ID:nBwbsXPR2a
Further company coverage: LCTX.A
((Briefs@thomsonreuters.com;))
Recent news on Lineage Cell Therapeutics
See all newsLineage Cell Therapeutics Q2 revenue falls but posts profit
Brief: Lineage Cell Therapeutics Q2 Income From Operations USD -8.923 Million
Lineage Cell Therapeutics Q1 net loss widens as expenses rise
Lineage Cell Q4 revenue rises on Genentech collaboration
Brief: Lineage Cell Therapeutics FY Income From Operations USD -36.619 Million